ERC Einstein Rockefeller CUNY Center for AIDS Research
ERC 爱因斯坦洛克菲勒纽约市立大学艾滋病研究中心
基本信息
- 批准号:10901422
- 负责人:
- 金额:$ 50.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcquired Immunodeficiency SyndromeAdvisory CommitteesBehavioralClinicalCollaborationsCommunicationCommunitiesCountyDevelopmentEducationElectronic MailEnsureEpidemicEpidemiologyFacultyFosteringFundingGoalsGrantGrowthHIVHIV InfectionsHIV diagnosisHealthInfrastructureInstitutionInterdisciplinary StudyInternationalLeadLeadershipLocationMedicineMental HealthMonitorNew York CityNewsletterOccupational activity of managing financesOutcomeOutcome MeasurePaperPerformanceProcessProductivityPublic Health SchoolsPublicationsRecommendationResearchResearch PersonnelResearch PriorityResourcesScientific Advances and AccomplishmentsStrategic PlanningStructureSurveysTrainingUnited StatesUnited States National Institutes of HealthUniversitiesUpdatecareercollegeimplementation processimprovedmeetingsmembermultidisciplinarynovel strategiesnovel therapeuticspreventprogramsrecruitresponsesoundsuccesssynergismuptakeweb siteworking group
项目摘要
PROJECT SUMMARY
ERC-CFAR: ADMINISTRATIVE CORE (AC)
The continued location of New York City (NYC) as an epicenters of the HIV epidemic, with four of
the 48 counties with the highest number of new HIV diagnoses targeted by the Ending the HIV
Epidemic in the U.S. (EHE) plan, makes NYC is an essential location for leveraging the capacity
of a CFAR to mobilize, lead, and coordinate the multidisciplinary research response required to
achieve the EHE goal of ending the HIV epidemic in the United States within 10 years. The
Einstein/Rockefeller/CUNY (ERC)-CFAR, led by the Administrative Core (AC), brings together,
synergizes and focuses researchers from the Albert Einstein College of Medicine (Einstein),
Rockefeller University (Rockefeller), and CUNY School of Public Health/Hunter College (CUNY),
as well as from the NYC Department of Health and Mental Hygiene (NYC DOHMH) on the
overarching goal of stopping new HIV infections. The Administrative Core (AC) coordinates ERC-
CFAR resources and activities to enable the collective ERC-CFAR research community to
accelerate their research developing novel strategies to increase uptake of current treatments
and discovering new approaches to prevent, treat, and functionally cure HIV. The AC guides the
ERC-CFAR using a Strategic plan which is updated annually in a process that integrates input
from our Executive, Steering, Internal and External Scientific Advisory Committees, and
Community Participatory Partnership and an annual membership survey. An metric indicating our
success during the previous funding period is a 30% increase in our OAR FRB from ~$34M to
~$44.7M and the publication by ERC-CFAR investigators of over 1,250 papers. We have obtained
an increased annual institutional commitment of $620K ($3.1 million over five years) from the
Einstein, Rockefeller, and CUNY leadership to further expand our activities. The AC provides
sound and dynamic financial management of the ERC-CFAR with the agility to reallocate funds
and realign Cores and Scientific Working Groups (SWGs) to support emerging high-priority
research directions from OAR/NIH initiatives and recommendations from our Internal and External
Scientific Advisory Boards. This is accomplished through the following four Specific Aims: 1) To
develop and implement a strategic planning process that will quantitatively and qualitatively
increase and improve collaborative, trans-institutional, interdisciplinary, and translational HIV
research among Einstein, Rockefeller, and CUNY investigators; 2) To utilize a responsive and
inclusive scientific leadership structure, Cores, and a SWG to drive synergism among Einstein,
Rockefeller, and CUNY investigators, and to coordinate and expand the investigative and
educational HIV activities at Einstein, Rockefeller, and CUNY; 3) To promote interactions of ERC-
CFAR investigators with other inter-CFAR activities and with NYC; and 4) To utilize outcome
measures to monitor success in meeting ERC-CFAR goals and programs.
项目总结
ERC-CFAR:管理核心(AC)
纽约市(NYC)继续成为艾滋病毒流行的中心,有四个
结束艾滋病的目标是新增艾滋病毒诊断人数最多的48个县
美国疫情(EHE)计划,使纽约市成为利用能力的关键地点
动员、领导和协调所需的多学科研究反应
实现在10年内结束美国艾滋病毒流行的目标。这个
爱因斯坦/洛克菲勒/纽约州立大学(ERC)-由行政核心(AC)领导的CFAR将
协同阿尔伯特·爱因斯坦医学院(爱因斯坦)的研究人员,
洛克菲勒大学(Rockefeller University)和纽约大学公共卫生学院/亨特学院(CUNY),
以及纽约市卫生和精神卫生部门(NYC DOHMH)关于
阻止新的艾滋病毒感染的首要目标。行政核心(AC)协调ERC-
CFAR资源和活动,使ERC-CFAR集体研究界能够
加速他们的研究,开发新的策略,以增加对当前治疗的吸收
以及发现预防、治疗和从功能上治愈艾滋病毒的新方法。交流电引导
ERC-CFAR使用战略计划,该战略计划在整合投入的过程中每年更新
来自我们的执行、指导、内部和外部科学咨询委员会,以及
社区参与伙伴关系和年度成员调查。一种表明我们的
在上一个资助期取得的成功是我们的Oar FRB增长了30%,从约3400万美元增加到
约4470万美元,以及ERC-CFAR调查人员发表的1250多篇论文。我们已经获得了
每年增加620,000美元的机构承诺(五年增加310万美元)
爱因斯坦、洛克菲勒和纽约市立大学的领导进一步扩大了我们的活动。AC提供
ERC-CFAR稳健、动态的财务管理,灵活地重新分配资金
并重新调整核心和科学工作组(SWG),以支持新出现的高优先事项
OAR/NIH倡议的研究方向和我们内部和外部的建议
科学顾问委员会。这是通过以下四个具体目标来实现的:1)
制定和实施战略规划过程,在数量和质量上
增加和改善协作性、跨机构、跨学科和转换性艾滋病毒
爱因斯坦、洛克菲勒和CUNY调查人员之间的研究;2)利用响应性和
包容性的科学领导结构、核心和SWG,以推动爱因斯坦之间的协同,
洛克菲勒和城市大学的调查人员,并协调和扩大调查和
爱因斯坦、洛克菲勒和纽约市立大学的艾滋病毒教育活动;3)促进ERC-
CFAR调查员与CFAR之间的其他活动和与纽约市的合作;以及4)利用结果
监测在满足ERC-CFAR目标和方案方面的成功程度的措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HARRIS GOLDSTEIN其他文献
HARRIS GOLDSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HARRIS GOLDSTEIN', 18)}}的其他基金
ERC Einstein-Rockefeller-CUNY Center for AIDS research
ERC 爱因斯坦-洛克菲勒-纽约市立大学艾滋病研究中心
- 批准号:
10901420 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
ERC Einstein-Rockefeller-CUNY Center for AIDS research
ERC 爱因斯坦-洛克菲勒-纽约市立大学艾滋病研究中心
- 批准号:
10458259 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
ERC Einstein Rockefeller CUNY Center for AIDS Research
ERC 爱因斯坦洛克菲勒纽约市立大学艾滋病研究中心
- 批准号:
10605257 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
Einstein-Rockefeller-CUNY Center for AIDS Research
爱因斯坦-洛克菲勒-纽约市立大学艾滋病研究中心
- 批准号:
9922220 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
ERC Einstein-Rockefeller-CUNY Center for AIDS research
ERC 爱因斯坦-洛克菲勒-纽约市立大学艾滋病研究中心
- 批准号:
10605256 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
ERC Einstein Rockefeller CUNY Center for AIDS Research
ERC 爱因斯坦洛克菲勒纽约市立大学艾滋病研究中心
- 批准号:
10458260 - 财政年份:2017
- 资助金额:
$ 50.63万 - 项目类别:
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
滥用药物以及控制 HIV 潜伏期的表观遗传和信号通路
- 批准号:
9038343 - 财政年份:2013
- 资助金额:
$ 50.63万 - 项目类别:
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
滥用药物以及控制 HIV 潜伏期的表观遗传和信号通路
- 批准号:
8683139 - 财政年份:2013
- 资助金额:
$ 50.63万 - 项目类别:
Drugs of abuse and the epigenetic and signaling pathways controlling HIV latency
滥用药物以及控制 HIV 潜伏期的表观遗传和信号通路
- 批准号:
8584850 - 财政年份:2013
- 资助金额:
$ 50.63万 - 项目类别:
Systems biology analysis of in vivo impact of substance abuse on HIV infection
药物滥用对 HIV 感染的体内影响的系统生物学分析
- 批准号:
8685627 - 财政年份:2012
- 资助金额:
$ 50.63万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 50.63万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 50.63万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 50.63万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 50.63万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 50.63万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 50.63万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 50.63万 - 项目类别: